Is Proteostasis Therapeutics (PTI) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 01/06/20
Proteostasis Therapeutics (PTI) in Focus: Stock Moves 7.3% HigherZacks Investment Research • 12/12/19
Proteostasis Therapeutics, Inc. (PTI) Shares March Higher, Can It Continue?Zacks Investment Research • 12/09/19
Are Options Traders Betting on a Big Move in Proteostasis Therapeutics (PTI) Stock?Zacks Investment Research • 11/27/19
Proteostasis Recruits Patients Quicker Than Anticipated, Results From CF Studies Now Expected Q4 2019Seeking Alpha • 11/12/19
Proteostasis Therapeutics (PTI) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/29/19
Proteostasis Therapeutics (PTI) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/07/19
Will Proteostasis Therapeutics (PTI) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/07/19
Proteostasis Therapeutics Rallies After Cystic Fibrosis Drug Is Granted Orphan DesignationBenzinga • 06/04/19
Proteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/19
Analysts Estimate Proteostasis Therapeutics (PTI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/01/19
Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock OptionsZacks Investment Research • 04/08/19
Proteostasis Therapeutics's stock plunges to pace all decliners after results of CF treatment trial disappointMarket Watch • 03/25/19